Support? Resistance? This company has been moving with the market. When things are going well investors jump in for the earnings potential and when the market tanks investors get out of high fliers. Today the market is going through the roof so UA is up big. Long term it is all about the earnings, which is predicated on UA managements initiatives.
If you have ever known anyone with Crohns this is a life changer for them and the sooner they get the product the better. It always feels good to make money but also to invest in businesses that help people cope with these terrible diseases.
I copied the news on another post. PPS has moved to all time high today. This what can happen when good news is aligned with a strong day in the market. You hate to see these results wasted on a crappy market day. We are up almost $13 to over $379. Over the long run stocks are driven by growth in earnings, but in the short run the over all market has a big effect.
Sanofi (SNY) and partner Regeneron Pharmaceuticals, Inc. (REGN) announced that the first patients have been dosed in a phase III study, LIBERTY AD CHRONOS, on pipeline candidate dupilumab.
Dupilumab works by blocking IL-4 and IL-13 signalling in adults and is being evaluated for the potential treatment of moderate-to-severe atopic dermatitis (AD.TO).
We note that LIBERTY AD CHRONOS is the first study (n=700) of the five trials in the phase III program on dupilumab. The primary endpoint of the randomized, double-blind, placebo-controlled study is to evaluate the efficacy of dupilumab in adults suffering from moderate-to-severe AD when administered concomitantly with topical corticosteroids through 16 weeks. The secondary endpoint of the study is to evaluate the long-term safety and efficacy of dupilumab up to 52 weeks.
Dupilumab was developed using Regeneron's pioneering VelocImmune technology. Apart from being evaluated for the treatment of AD, dupilumab is being evaluated for the potential treatment of asthma and chronic sinusitis with nasal polyposis.
Last month, Regeneron and Sanofi announced that dupilumab has met all primary and secondary endpoints in a randomized, double-blind, placebo-controlled phase IIa proof-of-concept study. The study evaluated dupilumab in patients (50% underwent prior surgery) suffering from moderate-to-severe chronic sinusitis with nasal polyps who did not respond to intranasal corticosteroids. Of the total number of patients, 58% also suffered from asthma.
The primary endpoint of the study was measured by the improvement in the size of nasal polyps. Dupilumab showed a statistically significant improvement in the size of nasal polyps. Moreover, dupilumab significantly improved objective measures of sinusitis by CT scan, nasal air flow and patient-reported symptoms including sense of smell, congestion, postnasal drip, runny nose and sleep disturbance.
We are encouraged by the pipeline progress.
The global hydrogen generation market is estimated to reach $138.2 billion by 2019, with a projected CAGR of 5.9%, signifying an increase in demand for a clean and emission free power source that is hydrogen
Hydrogen is the lightest and most common element which has a number of applications in chemical processing, petroleum recovery and refining, metal production and fabrication, aerospace, and fuel cells. The demand for hydrogen is largest in petroleum refinery and ammonia production. However, automotive fuel is an emerging sector with a huge potential in future. Hydrogen is considered to be environment friendly as electrochemical cells generate water vapor. Asia-Pacific is the leading market exhibiting high growth in hydrogen generation.
During petroleum refining, hydrogen is used for desulfurization and thus, the requirement of hydrogen in refineries depends on the sulfur level present in petroleum products. With the decrease of sulfur level in petroleum products, hydrogen requirement per unit of oil (intensity) increases. Governments are regulating sulfur content in final petroleum products hence; the demand for hydrogen generation is increasing. Hydrogen presents a cleaner option when used as a fuel to generate electricity since; it is produced by the electrolysis of water using renewable energies like wind, solar, and hydro. However, hydrogen production also faces challenges, as it lacks proper transportation and distribution infrastructure.
Airgas Inc. (U.S.), Air Products & Chemicals Inc. (U.S.), Linde AG (Germany), Praxair Inc. (U.S.), and Hydrogenics Corp. (Canada) are the major global players, in the hydrogen generation market.
By AMY REEVES, INVESTOR'S BUSINESS DAILY
Posted 11:32 AM ET
Big biotech Celgene (NASDAQ:CELG) rolled out more data on its new drug for Crohn's disease Tuesday, sending Celgene shares up 3% in the stock market today.
On Monday, Celgene released the abstract on the phase two trial of GED-0301, also called Mongersen, which showed good results for patients after two weeks of taking the drug. On Tuesday, it presented the full data at the United European Gastroenterology Week in Vienna, revealing that four-week and 12-week data were also strong.
ISI Group analyst was especially interested in the four-week data, since that gave him a point of comparison with drugs already on the market. At the 160-milligram dose, the remission rate for this period was 72%; for 40 mg it was 70%, while at 10 mg it was 29%. The remission rate for the placebo group was 14%, meaning that unlike in the two-week data, even the lowest dose of Mongersen produced a noticeable improvement.
By comparison, Johnson & Johnson's (NYSE:JNJ) Remicade typically produced a remission rate of 48% after four weeks. Biogen Idec's (NASDAQ:BIIB) historic rate is 32%, while AbbVie's (NYSE:ABBV) Humira's is 28.5%.
RBC Capital Markets analyst Michael Yee pointed out that these other drugs typically do $4 billion to $5 billion for the Crohn's disease indication (and they all have other indications in the immunology space since the diseases have similar mechanisms). He also noted that Mongersen's success continued in the 12-week data, with the highest-dose group maintaining a remission rate of 67%. There were no significant safety issues to report.
In Jan 2000 the S&P hit 1498 and then sold off. In Jul 2007 it hit 1526 and then sold off failing to break out. Finally in Mar 2013 we broke out past 1560 and have continued to where we are today. that Mar 2013 break out was significant. It is only the 4th time since 1900 that the S&P or earlier the DOW broke out. Each led to massive secular bull markets, the shortest from 1923 - late 1929 and the longest Aug 1982 to Jan 2000. Now the question is how long does it run?? & years or 18 years. In between there will be small set backs like we see now but this is temporary. The 1982 - 2000 move went from around 140 to 1498 or just under 11 times in 18 years. The DOW did even better during that period. Growing companies like UA can really run during a long bull market.
And today it is up to $1.35 in mid afternoon trading. Often stocks that hang in tough during down drafts have good moves higher when the general market turns around. Maybe this a prediction of an earnings beat. A bunch of those West Coast franchises opened up and could start to propel earnings higher. Personally, I love their coffee. We buy bags of it both regular and decaf for after dinner.
Nice call. Big announcement today on GED-301 and CELG up $4+. I have a decent investment here and tend not to follow it that closely. I listen to the conference calls and whenever they present at forums. I expect that CELG will contiue to move higher over time. They have a great pipe line and are well managed. I like stocks where I can trust the management. No BS just results.
As an aside: I have known people with Crohns and I applaud these results from a non investing aspect.
At the time of the split I believe that the general consensus was that PSX was just another refiner. Not many factored in that hidden behind that was 1/2 of a big chemical company (CPChem), 1/2 of a midstream MLP (DCP) and a lot of other midstream and pipeline assets owned directly by PSX. Since COP did not have a lot of debt, PSX was spun off with a great balance sheet. They also quickly announced that they would be investing very little capital in the refining business and beafing up midstream, chemicals and lubricants and marketing.
The stock actually traded down after the two week period, but when investors took a second look at the assets it took off.
First we need to get to $5 so that most funds will be able to buy the stock. 46.5% of the stock is held by insiders, but we need the pros to come in and hold a good percent of the other shares. Especially mutual funds because they will tend to hold longer than traders.
Nice analysis. I bought in about 1.5 years ago and am holding for the long pull. The real key here is that the management really know what they are doing. 5 years from now CELG owners won,t even remember this sell off. They will be too bust dancing in the street because of the price.
The problems are Europe 1st and then China. Remember this is an international corporation and earnings come form all over. The US cannot hold up the price of CMI by itself.
State-of-the-art facility will add jobs to the region and further expand the Company’s capacity to serve customers throughout the Midwest
RADNOR, Pa.--(BUSINESS WIRE)--
Airgas, Inc. (ARG), one of the nation's leading suppliers of industrial, medical, and specialty gases, and related products, today celebrated its new 250,000 square foot, state-of-the-art facility in Germantown, WI with a building dedication and tour. The new facility, which includes a distribution center and administrative office space, will expand and further streamline the Company’s hardgoods supply chain to Airgas customers and branch locations when it is fully operational in early December 2014. The facility will also be the new home for the regional Airgas Total Access™ telesales team that serves Airgas customers across much of the Midwest and Mountain States. Scott Walker, Governor of Wisconsin, and Dean Wolter, Germantown Village President, joined Airgas President and Chief Executive Officer Michael L. Molinini, President of Airgas USA, LLC Andrew R. Cichocki, Airgas associates, and residents of the Germantown community to celebrate the new facility.
“Airgas has been a part of the Germantown community for more than 17 years,” said Molinini. “We are very pleased to have found a new location that allows our distribution center, Airgas Total Access team, and support offices to remain in Germantown, while expanding our capacity to serve our customers and provide additional jobs to the region. We look forward to continuing our successful partnerships with the residents, businesses and civic associations of Greater Milwaukee for many years to come.”
Located on a 24-acre site, the facility will be twice the size of the Company’s current Germantown distribution center, located four miles away, while combining two existing office locations in the Milwaukee metropolitan area. Airgas will sell its preexisting distribution center. As a result of the expansion, the Company has hired 20 new associates to fill roles throughout the new facility and expects to hire an additional 60 associates by 2016.
The new distribution center is one of six that Airgas operates across the country. It will be used to stock and ship hardgoods, including welding equipment and safety products, to Airgas customers and branch locations throughout much of the Midwest. The facility will also include 58,000 square feet of office space for Airgas Total Access™ and for administrative support functions.
Any small drop in supply or increase in demand can send oil much higher. The world needs to replace about 5 million barrels a day every year because of degradation of existing wells.
Is 11/17 the date when OXY trades 3 ways?? I had COP prior to the split and if I remember correctly it also traded 3 ways 2 weeks prior to the first day that PSX was listed separately and not W/O.
State-of-the-art facility will add jobs to the region and further expand the Company’s capacity to serve customers throughout the Midwest
Airgas, Inc. (ARG), one of the nation's leading suppliers of industrial, medical, and specialty gases, and related products, today celebrated its new 250,000 square foot, state-of-the-art facility in Germantown, WI with a building dedication and tour. The new facility, which includes a distribution center and administrative office space, will expand and further streamline the Company’s hardgoods supply chain to Airgas customers and branch locations when it is fully operational in early December 2014. The facility will also be the new home for the regional Airgas Total Access™ telesales team that serves Airgas customers across much of the Midwest and Mountain States. Scott Walker, Governor of Wisconsin, and Dean Wolter, Germantown Village President, joined Airgas President and Chief Executive Officer Michael L. Molinini, President of Airgas USA, LLC Andrew R. Cichocki, Airgas associates, and residents of the Germantown community to celebrate the new facility.The new distribution center is one of six that Airgas operates across the country. It will be used to stock and ship hardgoods, including welding equipment and safety products, to Airgas customers and branch locations throughout much of the Midwest. The facility will also include 58,000 square feet of office space for Airgas Total Access™ and for administrative support functions.
The U.S. Surface Transportation Board, which oversees railroads, has a history of intervening between deals in the industry, according to the Journal. In 2000, a proposed merger of Burlington Northern and Canadian National Railway, Canadian Pacific Railway's larger rival, was dropped because of the agency's disapproval.
National security officials would also likely weigh in on a merger that combines a U.S. and Canadian company.
So we have a few individual situations where small companies have gone under, yet in the last 20 months from Jan 1, 2013 through August 31, 2014 Wisconsin has added 44,375 and the umemployment rate has gone down to 5.8% from 6.9%. September was a great month nationally and August was updated with big gains so my guess is that when the states are updated in the Bureau of Labor statistics Database then we will see even better numbers.
And the point of this site is to discuss Wisconsin Energy which is doing really well because of employment gains and a better business environment. It's not to hear some liberal cry baby wining because is guy didn't get elected.
My only concern short term is that investors get antsy owning these low price stocks when the market gets hammered. I think a lot of shares are held by local Texas investors who actually know the folks running this company. We can go back to when it was a valve company and when the valves were part of a machine shop that catered to the oil and gas industry. The current CEO was the chief financial officer. I believe that all those local folks know the value here and as a result I do not think there are many shares floating around to be had at any price. These kinds of companies attract traders and there is not enough volume to warrant that.